Owkin · Series B
Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care.
Amount
$180M
Round
Series B
Valuation
$1B
Announced
Nov 2021
Investors
Lead investor
Other Owkin rounds
| Date | Round | Amount | |
|---|---|---|---|
| Jan 2021 | Series A | $75M | Details → |